Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care

Biomed Res Int. 2015:2015:137020. doi: 10.1155/2015/137020. Epub 2015 Jan 5.

Abstract

Substance-related and addictive disorders are chronic relapsing conditions that substantially impact public health. Effective treatments for these disorders require addressing substance use/dependence comprehensively as well as other associated comorbidities. Comprehensive addressing of substance use in a medical setting involves screening for substance use, addressing substance use directly with the patient, and formulating an appropriate intervention. For alcohol dependence and opioid dependence, pharmacotherapies are available that are safe and effective when utilized in a comprehensive treatment paradigm, such as medication assisted treatment. In primary care, substance use disorders involving alcohol, illicit opioids, and prescription opioid abuse are common among patients who seek primary care services. Primary care providers report low levels of preparedness and confidence in identifying substance-related and addictive disorders and providing appropriate care and treatment. However, new models of service delivery in primary care for individuals with substance-related and addictive disorders are being developed to promote screening, care and treatment, and relapse prevention. The education and training of primary care providers utilizing approved medications for the treatment of alcohol use disorders and opioid dependence in a primary care setting would have important public health impact and reduce the burden of alcohol abuse and opioid dependence.

Publication types

  • Review

MeSH terms

  • Alcoholism / drug therapy*
  • Drug Monitoring
  • Drug Overdose / prevention & control
  • Humans
  • Opioid-Related Disorders / drug therapy*
  • Prescription Drugs / therapeutic use
  • Primary Health Care*

Substances

  • Prescription Drugs